Kevin W.

Kevin W. is an accomplished financial executive with extensive experience in various leadership roles within the healthcare, biopharma, and financial services sectors. Currently serving as Chief Financial Officer at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Kevin previously held CFO positions at Saban Community Clinic and Buddhist Tzu Chi Medical Foundation. Notably, Kevin established Bold Therapeutics Inc. as its first CFO, contributing to its governance and investor outreach efforts. With a background that includes co-founding Enliven Financial and advising on corporate finance at Ascendo Financial, Kevin has a proven track record in strategic financial management, capital raising, and organizational leadership. Kevin earned a Master of Science in Management, Banking and Financial Management from New England College and a BGS in Applied Sciences from Simon Fraser University.